He is responsible for the Life Science business sector, which he has led as CEO since 2014. Udit Batra, born on January 7, 1971 in New Delhi, India, joined the Executive Board of Merck KGaA, Darmstadt, Germany in April 2016. Press Release Template News Release Your Contact ... | November 5, 2015 Karl Hansen ... take notes and research excessively. The purpose of the Supervisory Board is to regularly advise and monitor Henkel Management AG and/or its Management Board in its stewardship of the company. Udit Batra, Member, Executive Board, Merck KGaA Darmstadt, Germany and CEO, Life Science, MilliporeSigma. Elmar Schnee was CEO of Cardiorentis in Zug, Switzerland from 2011–2013. By continuing your navigation, you consent to their use.
EMD Serono is the biopharmaceutical business of Merck KGaA, Darmstadt, Germany.
Shareholders hold around 30% of the total capital of Merck KGaA, and the Merck family owns an interest of around 70% via the general partner E. Merck KG which is represented by the Board of Partners. Merck & Co., Inc. makes no representations or warranties with respect to the information contained herein and takes no responsibility for supplementing, updating, or correcting and such information. Supervisory Board of Merck KGaA ; ; Supervisory Board XLS Memberships in Member (a) (b) other statutory supervisory boards and comparable German and foreign supervisory bodies of corporations Prof. Dr. Dr. h. c. Rolf Krebs Mainz Retired physician Chairman (as of July 23, 2009) (a) – Epigenomics AG, Berlin (Chairman) – Ganymed Pharmaceuticals Born 1959. The merger, which closed in November 2015, is the largest deal in the history of Merck KGaA, Darmstadt, Germany, and one of the largest in life science industry. John Moore Non-Executive Chairman. Karl Hansen. The organizational chart of Merck displays its 273 main executives including Kenneth Frazier, Robert Davis and Julie Gerberding × We use cookies to provide a better service. Board member since 2019. Education: Master’s degree in marketing and management from IMD.. Board Committees: Chairman of the Remuneration Committee.. Prior to that, he was responsible for the Consumer Health business. ... all investment decisions related to the APFC’s investment portfolio within the guidelines established by APFC’s Board of Trustees. Versum Materials’ Board of Directors to Review Unsolicited Tender Offer from Merck KGaA 26/03/2019 Versum Materials, Inc. (NYSE: VSM) today confirmed that Merck KGaA (Merck) has commenced an unsolicited tender offer to acquire all outstanding shares of …
Name The Merck tender offer is at the same price per share as the proposal made by Merck on February 27, 2019, which the Versum Board of Directors unanimously rejected on March 1, 2019. Board of Directors. Hakan joined Merck Ventures in 2013 and previously was investing as a partner at Aescap Venture and prior to that at Atlas Venture.
Non-Executive Chairman.
Elmar Schnee. Name/Title Current Board Membership; Wolfgang Heinz Büchele, 60 Chairman-Supervisory Board: Gelita AG, Merck KGaA, E. Merck KG, EPOTECH AG, Kemianteollisuus ry, … Director Cheminformatics, Merck KGaA ... Director at Merck.